About this trial
This multicenter registry study, which record the therapy strategy and follows up these acute ischemic stroke (AIS) patients with low NIHSS and large vessel occlusion (LVO), is intended to provide the important data for therapy evaluation and prognostic prediction of the LVO patients with low NIHSS.
Eligibility criteria
Qualifiers
Aged 18 years or older
Acute ischemic stroke patients of NIHSS 0-5 with 24 hours after onset
Proximal intracranial artery occlusion on NCCT/CTA or MRI/MRA showing occlusion of the intracranial ICA, M1, or proximal M2 vessel
Baseline ASPECTS ≥6 or infarct Core Volume of < 70 on NCCT/DWI/CTP
Disqualifiers
Any sign of intracranial hemorrhage on baseline CT/MR;
Seizures at stroke onset
Baseline blood glucose of <2.78 mmol or >22.20 mmol, or platelet count < 100,000/uL or serum creatinine levels > 3.0 mg/dL
Participation in any investigational study in the previous 30 days
Trial design
Treatments tested in this trial
- Immediate endovascular therapy